Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Apr. 28, 2012	Apr. 30, 2011
Cash flows from operating activities:
Net loss	$ (13,075)	$ (3,755)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Amortization of deferred financing costs	224	224
Depreciation and amortization	1,934	1,876
(Benefit) provision for losses on accounts receivable	(43)	296
Share-based compensation expense	3,806	7
Change in operating assets and liabilities net of effect of acquisition:
Accounts receivable	7,451	(1,315)
Inventories	584	4,686
Prepaid expenses and other assets	3,670	195
Accounts payable	2,103	11,866
Accounts payable-affiliates	(8,382)	(2,092)
Accrued expenses and other liabilities and other long-term liabilities	410	1,944
Net cash (used in) provided by operating activities	(1,318)	13,932
Cash flows from investing activities:
Additions to property and equipment	(1,353)	(436)
Payment to acquire Parlux, net of Parlux cash on hand of $17,114	(44,949)	0
Net cash used in investing activities	(46,302)	(436)
Cash flows from financing activities:
Net borrowings under bank line of credit	18,527	(12,839)
Payments on affiliated notes payable	0	(160)
Borrowings under affiliated notes payable to fund Parlux acquisition	30,000	0
Principal payments under capital lease obligations	(265)	(326)
Payments of long-term debt and other	0	(39)
Proceeds from exercise of stock options	4	0
Net cash provided by (used in) financing activities	48,266	(13,364)
Increase in cash and cash equivalents	646	132
Cash and cash equivalents at beginning of period	1,682	1,236
Cash and cash equivalents at end of period	2,328	1,368
Supplemental Information:
Cash paid during the period for Interest	322	591
Cash paid during the period for Income taxes	66	80
Fair value of equity consideration given to acquire Parlux	$ 83,595	$ 0